Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047134 | SCV001211071 | uncertain significance | not provided | 2021-03-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with ELP1-related conditions. This variant is present in population databases (rs764767995, ExAC 0.002%). This sequence change replaces valine with phenylalanine at codon 105 of the ELP1 protein (p.Val105Phe). The valine residue is moderately conserved and there is a small physicochemical difference between valine and phenylalanine. |
Natera, |
RCV001827295 | SCV002082178 | uncertain significance | Familial dysautonomia | 2020-12-08 | no assertion criteria provided | clinical testing |